Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Barak Tanzman

Plastic and Reconstructive Surgery Berkley, MI Doctor of Osteopathy

NPI 1457539116 CMS profile 202262

27901 Woodward Ave, Suite 100, Berkley, MI 48072

Open in the dashboard

General payments

$70,472

246 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Barak Tanzman of Berkley, MI is reported in the CMS Open Payments database as having received $70,472 across 246 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,792 40
2024 General $13,691 31
2023 General $13,091 47
2022 General $9,342 39
2021 General $3,790 21
2020 General $4,540 22
2019 General $6,226 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Barak Tanzman
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Barak Tanzman were reported at $19,792. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Barak Tanzman Plastic and Reconstructive Surgery median Middle half National median
2019 $6,226 $335 $121–$1,264 $163
2020 $4,540 $162 $57–$417 $114
2021 $3,790 $245 $89–$735 $132
2022 $9,342 $325 $120–$932 $149
2023 $13,091 $343 $129–$999 $160
2024 $13,691 $390 $141–$1,085 $164
2025 $19,792 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Kerecis Limited $42,792 35 payments
  2. TELA Bio, Inc. $6,272 55 payments
  3. PolarityTE, Inc. $3,844 14 payments
  4. Allergan Inc. $3,762 19 payments
  5. AbbVie, Inc. $2,863 22 payments
  6. AxoGen $1,899 8 payments
  7. Integra LifeSciences Corporation $1,731 19 payments
  8. KCI USA, Inc $939 3 payments
  9. Access Pro Medical, LLC $691 6 payments
  10. Mentor Worldwide LLC $605 8 payments
  11. Other $5,074 57 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $26,700 8 payments
  2. Food and Beverage $20,149 212 payments
  3. Travel and Lodging $8,578 13 payments
  4. Consulting Fee $7,800 4 payments
  5. Honoraria $4,175 4 payments
  6. Education $2,500 2 payments
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $400 1 payment
  8. Gift $152 1 payment
  9. Entertainment $18 1 payment
Products named General payments · program years 2019–2025
  1. Kerecis Omega3 SurgiClose $24,467 18 payments
  2. Kerecis SurgiClose Wound Care $17,608 15 payments
  3. Kerecis GraftGuide $17,608 15 payments
  4. Kerecis SurgiClose Wound Care $17,608 15 payments
  5. Kerecis SurgiClose Wound Care $17,608 15 payments
  6. Kerecis SurgiClose Wound Care $17,608 15 payments
  7. Kerecis Omega3 Marigen Wound Care $17,445 14 payments
  8. Kerecis Omega3 GraftGuide $12,885 7 payments
  9. Kerecis Omega3 Marigen Wound Care $11,583 11 payments
  10. Kerecis Omega3 Marigen Wound Care $11,583 11 payments
  11. Other $86,790 321 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$101

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

100%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $101

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$16,923

Medicare's payments for the services billed

Medicare patients

20

Average age 71

Services billed

88

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 60%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $124
$124 — —
BOTOX
  • AbbVie, Inc. $110
$110 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

246 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record